Vistagen Therapeutics Statistics
NASDAQ: VTGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.1636-0.023 (-12.33%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Vistagen Therapeutics by the numbers
Vistagen Therapeutics has a market capitalization of $7.6 million based on 46.19M shares outstanding. With trailing EPS of $-1.36, Vistagen Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.7% below its 50-day average and 60.5% below its 200-day average.
Average daily trading volume is 10.30M shares, or about $1.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VTGN valuation vs. peer median
| Metric | VTGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $7.56M | $7.33M | +3% |
| Avg. volume | 10.30M | 415.77K | +2378% |
Peer median across 8 companies: RKTO, PHIO, IMRN, CLRB, DARE, CVKD, ENSC, TCRT.
Valuation
- Market cap
- $7.56M
- Price / sales (latest FY)
- 5.95
- EPS (TTM)
- $-1.36
- Shares outstanding
- 46.19M
Price and trading
- Previous close
- 0.1866
- Open
- 0.185
- Day range
- 0.1635 – 0.1915
- 52-week range
- 0.16 – 5.14
- 52-week change
- -96.44%
- 50-day moving average
- 0.2174
- Beta
- —
- Volume
- 908.86K
- Average volume
- 10.30M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 13, 2026
Additional statistics
- Market Cap
- 7.56M
- Forward Pe
- -0.13
- Eps
- -1.36
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.14
- Week52 Low
- 0.16
- Avg Volume
- 10.30M
- Shares Outstanding
- 46.19M
- Ma50
- 0.22
- Ma200
- 0.41
- Earnings Date
- Nov 13, 2026
- Pct From52w High
- -96.82%
- Pct From52w Low
- 2.25%